IMUNON announces $10M cash financing
Source: SeekingAlpha
2026-06-04 08:17:35 ET
More on Imunon
- Imunon targets OVATION 3 last patient enrollment in Q1 2029 while outlining preferred-share financing options
- Imunon targets ~80 OVATION 3 patients in the next 12 months as cash runway extends into H2 2026
- Seeking Alpha’s Quant Rating on Imunon
Read the full article on Seeking Alpha
For further details see:
IMUNON announces $10M cash financing
Imunon Inc.
NASDAQ: IMNN
IMNN Trading
0.48% G/L:
$2.09 Last:
62,604 Volume:
$2.17 Open:
IMNN Latest News
May 12, 2026 08:00:00 am
IMUNON Reports First Quarter 2026 Financial Results and Provides Business Update
IMNN Stock Data
$11,164,462
3,034,410
N/A
8
N/A
Biotechnology & Life Sciences
Healthcare
US
Lawrenceville
